報價延遲最少15分鐘:2025/04/12 04:12 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
3.815 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-3.68/-2.47
|
|
企業價值
55.22M
|
| 資產負債 |
|
每股賬面淨值
-1.15
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
326.00K
|
|
每股收益
0.04
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/04/12 04:12 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech. |